Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Gancyclovir Gel for Herpes Zoster Keratitis
NCT02382588Phase 2Terminated
- Sponsor
- Northwestern University
- Start
- Dec 2013
- Primary completion
- May 2020
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ganciclovir in herpes zoster keratitis (HZK) (2 arms), sponsored by Northwestern University. Primary endpoint: Corneal Ulcer Healing at 2 weeks. Started Dec 2013; status: terminated.
02
Drugs
ganciclovir
03
Conditions
herpes zoster keratitis (HZK)
Beyond the preview
Go deeper on NCT02382588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02382588.